DRUG

DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc. · NASDAQ
Market Closed
20.40
▼ ⁦-1.45%⁩ (-0.30)
Post-market20.400.00% (0.00)
Market Cap$201.2M
Beta0.09
52w Low52w High
17.40123.75
Last Week
⁦-11.73%⁩
Last Month
⁦-61.28%⁩
Last 3 Months
⁦-73.52%⁩
Last Year
⁦-64.83%⁩
Open on chart
Premium content
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$700 / yr
Monthly plan
$99 / mo
Premium content
Which listings have analyst coverage?

EL7 refreshes analyst ratings and price targets for active company listings on Nasdaq, the New York Stock Exchange and NYSE American, including US-listed depositary receipts. Funds (including ETFs and mutual funds), OTC listings and listings on other exchanges are outside this coverage. Some eligible listings may have no published target or analyst call in the past 12 months.

EL7 checks for new ratings several times on weekdays, refreshes consensus targets on weekdays and updates monthly rating history once a month.

Financial Analysis
Related News

Frequently Asked Questions

What is Bright Minds Biosciences Inc. stock?▼

Bright Minds Biosciences Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in Bright Minds Biosciences Inc.?▼

You can buy Bright Minds Biosciences Inc. shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating Bright Minds Biosciences Inc.?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does Bright Minds Biosciences Inc. pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in Bright Minds Biosciences Inc.?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.